Prognostic value of total triiodothyronine and free thyroxine levels for the heart failure in patients with acute myocardial infarction
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Although a low triiodothyronine (T3) state is closely associated with heart failure (HF), it is uncertain whether total T3 levels on admission is correlated with the clinical outcomes of acute myocardial infarction (AMI). The aim of this study is to investigate the prognostic value of total T3 levels for major adverse cardiovascular and cerebrovascular events (MACCEs) in patients with AMI undergone percutaneous coronary intervention (PCI). Methods: A total of 765 PCI-treated AMI patients (65.4 ± 12.6 years old, 215 women) between January 2012 and July 2014 were included and 1-year MACCEs were analyzed. We assessed the correlation of total T3 and free thyroxine (fT4) with prevalence of 1-year MACCEs and the predictive values of total T3, fT4, and the ratio of total T3 to fT4 (T3/fT4), especially for HF requiring re-hospitalization. Results: Thirty patients (3.9%) were re-hospitalized within 12 months to control HF symptoms. Total T3 levels were lower in the HF group than in the non-HF group (84.32 ± 21.04 ng/dL vs. 101.20 ± 20.30 ng/dL, p < 0.001). Receiver operating characteristic curve analysis showed the cut-offs of total T3 levels (≤ 85 ng/dL) and T3/fT4 (≤ 60) for HF (area under curve [AUC] = 0.734, p < 0.001; AUC = 0.774, p < 0.001, respectively). In multivariate analysis, lower T3/fT4 was an independent predictor for 1-year HF in PCI-treated AMI patients (odds ratio, 1.035; 95% confidential interval, 1.007 to 1.064; p = 0.015). Conclusions: Lower levels of total T3 were well correlated with 1-year HF in PCI-treated AMI patients. The T3/fT4 levels can be an additional marker to predict HF.
Abstract
Background/Aims: Although a low triiodothyronine (T3) state is closely associated with heart failure (HF), it is uncertain whether total T3 levels on admission is correlated with the clinical outcomes of acute myocardial infarction (AMI). The aim of this study is to investigate the prognostic value of total T3 levels for major adverse cardiovascular and cerebrovascular events (MACCEs) in patients with AMI undergone percutaneous coronary intervention (PCI). Methods: A total of 765 PCI-treated AMI patients (65.4 ± 12.6 years old, 215 women) between January 2012 and July 2014 were included and 1-year MACCEs were analyzed. We assessed the correlation of total T3 and free thyroxine (fT4) with prevalence of 1-year MACCEs and the predictive values of total T3, fT4, and the ratio of total T3 to fT4 (T3/fT4), especially for HF requiring re-hospitalization. Results: Thirty patients (3.9%) were re-hospitalized within 12 months to control HF symptoms. Total T3 levels were lower in the HF group than in the non-HF group (84.32 ± 21.04 ng/dL vs. 101.20 ± 20.30 ng/dL, p < 0.001). Receiver operating characteristic curve analysis showed the cut-offs of total T3 levels (≤ 85 ng/dL) and T3/fT4 (≤ 60) for HF (area under curve [AUC] = 0.734, p < 0.001; AUC = 0.774, p < 0.001, respectively). In multivariate analysis, lower T3/fT4 was an independent predictor for 1-year HF in PCI-treated AMI patients (odds ratio, 1.035; 95% confidential interval, 1.007 to 1.064; p = 0.015). Conclusions: Lower levels of total T3 were well correlated with 1-year HF in PCI-treated AMI patients. The T3/fT4 levels can be an additional marker to predict HF.
참고문헌 (23)
- Klein I, "Thyroid hormone and the cardiovascular system", N Engl J Med, 344, pp.501~509 (2001)[DOI]
- Klein I, "Thyroid disease and the heart", Circulation, 116, pp.1725~1735 (2007)[DOI]
- Friberg L, "Association between increased levels of reverse triiodothyronine and mortality after acute myocardial infarction", Am J Med, 111, pp.699~703 (2001)[DOI]
- Mancini A, "Thyroid hormones, oxidative stress, and inflammation", Mediators Inflamm, 2016, pp.6757154~ (2016)
- Iervasi G, "Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease", Circulation, 107, pp.708~713 (2003)[DOI]
- Zhang B, "A low fT3 level as a prognostic marker in patients with acute myocardial infarctions", Intern Med, 51, pp.3009~3015 (2012)[DOI]
- Lazzeri C, "Nonthyroidal illness syndrome in ST-elevation myocardial infarction treated with mechanical revascularization", Int J Cardiol, 158, pp.103~104 (2012)[DOI]
- Levine GN, "2015 ACC", AHA, AHA, pp.SCAI guideline for percutaneous coronary intervention and the 2013 ACCF, AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology[DOI]
- de Vries EM, "The molecular basis of the non-thyroidal illness syndrome", J Endocrinol, 225, pp.R67~R81 (2015)[DOI]
- Lymvaios I, "Thyroid hormone and recovery of cardiac function in patients with acute myocardial infarction: a strong association?", Eur J Endocrinol, 165, pp.107~114 (2011)[DOI]
- Selvaraj S, "Association of serum triiodothyronine with B-type natriuretic peptide and severe left ventricular diastolic dysfunction in heart failure with preserved ejection fraction", Am J Cardiol, 110, pp.234~239 (2012)[DOI]
- Ascheim DD, "Thyroid hormone metabolism in patients with congestive heart failure: the low triiodothyronine state", Thyroid, 12, pp.511~515 (2002)[DOI]
- Pingitore A, "Triiodothyronine levels for risk stratification of patients with chronic heart failure", Am J Med, 118, pp.132~136 (2005)[DOI]
- Liu Y, "Regulation of arteriolar density in adult myocardium during low thyroid conditions", Vascul Pharmacol, 52, pp.146~150 (2010)[DOI]
- Franklyn JA, "Thyroid status in patients after acute myocardial infarction", Clin Sci (Lond), 67, pp.585~590 (1984)[DOI]
- Pimentel RC, "Thyroid hormone profile in acute coronary syndromes", Arq Bras Cardiol, 87, pp.688~694 (2006)
- Ojamaa K, "Thyroid hormone metabolism and cardiac gene expression after acute myocardial infarction in the rat", Am J Physiol Endocrinol Metab, 279, pp.E1319~E1324 (2000)[DOI]
- Olivares EL, "Thyroid function disturbance and type 3 iodothyronine deiodinase induction after myocardial infarction in rats a time course study", Endocrinology, 148, pp.4786~4792 (2007)[DOI]
- Wang WY, "Free triiodothyronine level indicates the degree of myocardial injury in patients with acute ST-elevation myocardial infarction", Chin Med J (Engl), 126, pp.3926~3929 (2013)
- Van den Berghe G, "Non-thyroidal illness in the ICU: a syndrome with different faces", Thyroid, 24, pp.1456~1465 (2014)[DOI]
- Wilcox RB, "Heterogeneity in affinities of serum proteins for thyroxine among patients with non-thyroidal illness as indicated by the serum free thyroxine response to serum dilution", Eur J Endocrinol, 131, pp.9~13 (1994)[DOI]
- Kaptein EM, "Thyroxine transfer and distribution in critical nonthyroidal illnesses, chronic renal failure, and chronic ethanol abuse", J Clin Endocrinol Metab, 65, pp.606~616 (1987)[DOI]
- McIver B, "Euthyroid sick syndrome: an overview", Thyroid, 7, pp.125~132 (1997)[DOI]